Contact
searchSearch
HMP Global

News

News
IBS Associated With 35% Higher Long-Term Risk of Psoriasis
08/12/2026
Jessica Garlewicz
Patients with irritable bowel syndrome (IBS) had a 35% higher risk of developing psoriasis compared with those without IBS in a large prospective cohort study.
Patients with irritable bowel syndrome (IBS) had a 35% higher risk of developing psoriasis compared with those without IBS in a large prospective cohort study.
Patients with irritable bowel...
08/12/2026
The Dermatologist
News
Psoriasis Associated With Increased Risk of Acute Periapical Abscesses
08/12/2026
Jessica Garlewicz
Patients with psoriasis had a significantly higher prevalence of acute periapical abscesses, with the association persisting after adjustment for several medical, behavioral, and treatment-related factors.
Patients with psoriasis had a significantly higher prevalence of acute periapical abscesses, with the association persisting after adjustment for several medical, behavioral, and treatment-related factors.
Patients with psoriasis had a...
08/12/2026
The Dermatologist
News
Patients, Dermatology Providers Support Telemedicine for Stable Psoriasis, Atopic Dermatitis
08/12/2026
Jessica Garlewicz
Patients with stable psoriasis or atopic dermatitis receiving systemic treatment and dermatological care providers reported positive attitudes toward telemedicine.
Patients with stable psoriasis or atopic dermatitis receiving systemic treatment and dermatological care providers reported positive attitudes toward telemedicine.
Patients with stable psoriasis...
08/12/2026
The Dermatologist
News
Expert Consensus Addresses Malignancy Risk With Targeted Therapies for Psoriasis, Atopic Dermatitis
08/12/2026
Jessica Garlewicz
The growing use of biologic and oral targeted therapies has expanded treatment options for psoriasis and atopic dermatitis, including among patients with cancer-related risks.
The growing use of biologic and oral targeted therapies has expanded treatment options for psoriasis and atopic dermatitis, including among patients with cancer-related risks.
The growing use of biologic and...
08/12/2026
The Dermatologist
IBD
News
Bibliometric Analysis Highlights Expanding Focus on the Atopic Dermatitis-Inflammatory Bowel Disease Connection
07/07/2026
Jessica Garlewicz
Research exploring the relationship between atopic dermatitis and inflammatory bowel disease has grown substantially over the past 2 decades, with increasing emphasis on shared disease mechanisms and translational therapeutic strategies.
Research exploring the relationship between atopic dermatitis and inflammatory bowel disease has grown substantially over the past 2 decades, with increasing emphasis on shared disease mechanisms and translational therapeutic strategies.
Research exploring the...
07/07/2026
The Dermatologist
AD
News
Study Finds Treat-to-Target Goals Remain Difficult to Achieve in Atopic Dermatitis
07/07/2026
Jessica Garlewicz
Most adults with atopic dermatitis receiving long-term treatment did not achieve a comprehensive treat-to-target goal that incorporated both physician- and patient-reported outcomes.
Most adults with atopic dermatitis receiving long-term treatment did not achieve a comprehensive treat-to-target goal that incorporated both physician- and patient-reported outcomes.
Most adults with atopic...
07/07/2026
The Dermatologist
AD
News
AI-Augmented Review Identifies Key Biomarkers in Childhood Atopic Dermatitis
07/07/2026
Jessica Garlewicz
An AI-assisted systematic review has synthesized evidence across genetic, immune, microbial, and metabolic biomarkers in childhood atopic dermatitis.
An AI-assisted systematic review has synthesized evidence across genetic, immune, microbial, and metabolic biomarkers in childhood atopic dermatitis.
An AI-assisted systematic review...
07/07/2026
The Dermatologist
Psoriasis
News
Prediction Models May Improve Early Identification of Psoriatic Arthritis in Patients With Psoriasis
07/07/2026
Jessica Garlewicz
Researchers have developed and internally validated prediction models designed to identify patients with psoriasis at increased risk for psoriatic arthritis.
Researchers have developed and internally validated prediction models designed to identify patients with psoriasis at increased risk for psoriatic arthritis.
Researchers have developed and...
07/07/2026
The Dermatologist
psoriasis
News
Transcriptomic Analysis Identifies Dual Th17/Type 2 Immune Signature in Taiwanese Patients With Psoriasis
07/07/2026
Jessica Garlewicz
Although the IL-23/Th17 axis is recognized as a central driver of psoriasis, molecular heterogeneity across different ethnic populations has not been well characterized.
Although the IL-23/Th17 axis is recognized as a central driver of psoriasis, molecular heterogeneity across different ethnic populations has not been well characterized.
Although the IL-23/Th17 axis is...
07/07/2026
The Dermatologist
PsO
News
Study Identifies 3 Candidate Biomarkers Associated With T-Cell Infiltration in Psoriasis
07/07/2026
Jessica Garlewicz
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated immune responses, with T cells playing a central role in disease pathogenesis.
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated immune responses, with T cells playing a central role in disease pathogenesis.
Psoriasis is a chronic...
07/07/2026
The Dermatologist

Popular Articles

Brain
Quiz
Barriers to Mental Health Support
10/10/2024
Riya Gandhi, MA
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
Riya Gandhi, MA
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
NRS Approved Features
Myths and Updates in Rosacea Treatment
10/07/2024
Linda Stein Gold, MD
Dispelling common misconceptions about the disease and advancing the development of more tolerable topical and oral therapies can offer hope for improved patient outcomes.
Dispelling common misconceptions about the disease and advancing the development of more tolerable topical and oral therapies can offer hope for improved patient outcomes.
Dispelling common misconceptions...
10/07/2024
The Dermatologist
Clinical Insights
Treating Acne Sequelae
09/06/2024
Riya Gandhi, MA
There are many new devices available to target the aftereffects of acne, allowing dermatologists to tailor treatment plans for the best possible patient outcomes.
There are many new devices available to target the aftereffects of acne, allowing dermatologists to tailor treatment plans for the best possible patient outcomes.
There are many new devices...
09/06/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive

Latest Quizzes and Trivia

AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use